Browse by author
Lookup NU author(s): Dr James Orr
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Translational medicine, rather than being a unidirectional clinical utilization of basic research discoveries, should be a bidirectional process of cross-fertilization between basic science, medical knowledge and clinical utilization. While steps and processes differ across these branches of research, clear language and proper definitions are prerequisites for effective interaction of researchers to facilitate knowledge development. With respect to Hepatic Encephalopathy, at first glance the areas which require development are around prevention, both to reduce the risk of relapse following an episode of overt HE and to reduce the risk of the first episode of HE. In addition, shortening the duration of episodes of overt HE may also be relevant. Comparisons of treatments and combinations of treatments, acting by different but potentially synergistic mechanisms, are reasonable targets for both basic and applied research.
Author(s): Amodio P, Montagnese S, Mullen K, Orr JG, Vilstrup H
Publication type: Article
Publication status: Published
Journal: Metabolic Brain Disease
Year: 2016
Volume: 31
Issue: 6
Pages: 1231-1237
Print publication date: 01/12/2016
Online publication date: 09/09/2015
Acceptance date: 02/09/2015
ISSN (print): 0885-7490
ISSN (electronic): 1573-7365
Publisher: Springer
URL: http://dx.doi.org/10.1007/s11011-015-9728-3
DOI: 10.1007/s11011-015-9728-3
Altmetrics provided by Altmetric
